Announcements Trials

Browse Landscape

Phase

Phase 1/2 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Transitional Cell 14 Urinary Bladder Neoplasms 13 Colorectal Neoplasms 10 Carcinoma, Merkel Cell 9 Breast Neoplasms 9 Carcinoma, Renal Cell 7 Neoplasms 6 Neoplasm Metastasis 6 Carcinoma, Non-Small-Cell Lung 6 Small Cell Lung Carcinoma 4 Carcinoma, Hepatocellular 4 Turcot syndrome 3 Stomach Neoplasms 3 Neuroendocrine Tumors 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Urethral Neoplasms 2 Ureteral Neoplasms 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Penile Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Melanoma 2 Lung Neoplasms 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Neuroendocrine 2 Uterine Cervical Neoplasms 1

Interventions

Cisplatin 24 Carboplatin 19 Paclitaxel 18 pembrolizumab 12 Gemcitabine 12 Radiotherapy 9 Fluorouracil 9 Specimen Handling 8 Magnetic Resonance Spectroscopy 7 cemiplimab 6 Platinum 6 Nivolumab 6 Docetaxel 6 Cetuximab 6 1,2-diaminocyclohexaneplatinum II citrate 6 epothilone B 5 anlotinib 5 Sunitinib 5 Pemetrexed 5 Oxaliplatin 5 Everolimus 5 Drug Therapy 5 Cyclophosphamide 5 Capecitabine 5 Bevacizumab 5 durvalumab 4 Radiotherapy, Intensity-Modulated 4 Radiation 4 Erlotinib Hydrochloride 4 Celecoxib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma × avelumab × Clear all

NCT04698213 2021-01-06

TIDE-A

Consorzio Oncotech

Phase 2 Unknown

Carcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡